How much CBD oil is right for my cat?
Again, we recommend working with your vet to work out a dose that is best for his or her condition. However, as a general guideline, you can start at 1mg per 10lbs of cat weight, twice daily.
Since different CBD products on the market can have very different concentrations of CBD, you need to be careful about making sure you dose properly to the actual product you use.
For example, with Lolahemp tinctures, 2 drops = 1 mg of CBD. Note that this dropper guideline will not be the same with other brands so be careful when calculating dosing.
The general rule when using any hemp products is to start low, and increase slowly until the desired effects are achieved. If you notice any side effects such as nausea, drooling, excess tiredness, or tremors of any kind it is wise to stop giving CBD to your cat and consult with your vet.
What if my vet won’t talk to me about CBD?
Up until just recently, hemp based products had questionable legal standing. However, the 2018 Farm Bill made hemp and hemp products legal in the U.S.
Further complicating matters is the fact that many veterinarians are restricted from discussing CBD with their clients due to restrictive or unclear state veterinary licensing requirements.
Some veterinarians, such as those in California, have even had to resort to legislative action to gain protections for discussing the potential therapeutic values of cannabis based medicine with their clients.
If your vet is unwilling to discuss using CBD for your cat, you may want to consult with a holistic veterinarian. These vets have additional training that includes the use of natural products, known as nutraceuticals, in their clinical practices. Because these vets are often more experienced at the use of CBD with pets, they are often a better resource for informed cat owners.
How do I make sure to get a high quality CBD oil for my cat?
One of the most important things you can do to help your cat is to do your research before buying any CBD or hemp product for them.
The reason for this is that the demand for CBD pet products is exploding right now as word of mouth spreads as to how effective it can be. And, unfortunately some companies are taking advantage of that by selling low quality or even harmful products.
Here at Lolahemp, quality is our number one priority. Here are some of the key features that make Lolahemp CBD the right choice for your cat:
We start with hand harvested organic hemp grown by a family farm in Colorado.
We test our products three times from seed to bottle.
We offer third party lab testing for every single batch of our oil, tied to a QR code on every product we sell.
We offer a robust full spectrum CBD oil made just for pets.
Our products contain no harmful additives such as artificial flavors or sweeteners that can be toxic to pets.
We include accurate and veterinarian recommended dosing guidelines for our products.
We use MCT coconut oil for our carrier oil, considered ideal for optimal cannabinoid absorption.
We are a Pets Before Profits company with a strong commitment to animal welfare.
Is there any scientific research on CBD oil?
It is no surprise that veterinary medical research is often several years behind when it comes to setting up clinical trials and testing new medications and supplements. However, research on CBD and hemp have been going on for decades.
Below you can find a list of links to helpful research studies on CBD. Each link goes to a primary scientific paper published in peer reviewed scientific journals.
Anxiety
Wright M, Di Ciano P, Brands B. Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. Cannabis and Cannabinoid Research. 2020.
Jurkus R, Day HLL, Guimarães FS, Lee JLC, Bertoglio LJ, Stevenson CW. Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders. Front Pharmacol. 2016;7:454.
Masataka N. Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders. Front Psychol. 2019;10:2466.
Assareh N, Gururajan A, Zhou C, Luo JL, Kevin RC, Arnold JC. Cannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice. Behav Pharmacol. May 2020.
Zieba J, Sinclair D, Sebree T, et al. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism. Pharmacol Biochem Behav. 2019;181:93-100.
Arthritis
Philpott HT, O’Brien M, McDougall JJ. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017;158(12):2442.
Gamble L-J, Boesch JM, Frye CW, et al. Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs. Front Vet Sci. 2018;5:165.
Malfait AM, Gallily R, Sumariwalla PF, et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 2000;97(17):9561-9566.
Digestion and Gut Health
Izzo AA, Muccioli GG, Ruggieri MR, Schicho R. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease. Handb Exp Pharmacol. 2015;231:423-447.
Capasso R, Borrelli F, Aviello G, et al. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. Br J Pharmacol. 2008;154(5):1001-1008.
De Filippis D, Esposito G, Cirillo C, et al. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 2011;6(12):e28159.
Couch DG, Cook H, Ortori C, Barrett D, Lund JN, O’Sullivan SE. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo—A Randomized, Placebo-controlled, Double-blind Controlled Trial. Inflammatory Bowel Diseases. 2019;25(6):1006-1018.
Drug Interactions
Bornheim LM, Grillo MP. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem Res Toxicol. 1998;11(10):1209-1216.
Full Spectrum and the Entourage Effect
Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochim Biophys Acta Mol Basis Dis. 2020;1866(7):165771.
Hecksel R, LaVigne J, Streicher JM. In Defense of the “Entourage Effect”: Terpenes Found in Cannabis sativa Activate the Cannabinoid Receptor 1 In Vitro. The FASEB Journal. 2020;34(S1):1-1.
Russo EB. The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No “Strain,” No Gain. Frontiers in Plant Science. 2019;9.
Ferber SG, Namdar D, Hen-Shoval D, et al. The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders. Current Neuropharmacology. 2020;18(2):87-96.
Inflammation
Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorg Med Chem. 2015;23(7):1377-1385.
Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease. Eur J Rheumatol Inflamm. 2017;4(3):210-218.
Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochim Biophys Acta Mol Basis Dis. 2020;1866(7):165771.
De Filippis D, Esposito G, Cirillo C, et al. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 2011;6(12):e28159.
Staton PC, Hatcher JP, Walker DJ, et al. The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain. 2008;139(1):225-236.
Nausea
Parker LA, Mechoulam R, Schlievert C. Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats. Neuroreport. 2002;13(5):567-570.
Rock EM, Bolognini D, Limebeer CL, et al. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus. Br J Pharmacol. 2012;165(8):2620-2634.
Pain
Barrie N, Manolios N. The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease. Eur J Rheumatol Inflamm. 2017;4(3):210-218.
Staton PC, Hatcher JP, Walker DJ, et al. The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain. 2008;139(1):225-236.
Philpott HT, O’Brien M, McDougall JJ. Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain. 2017;158(12):2442.
Gregorio DD, De Gregorio D, McLaughlin RJ, et al. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. PAIN. 2019;160(1):136-150.
Genaro K, Fabris D, Arantes ALF, Zuardi AW, Crippa JAS, Prado WA. Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats. Front Pharmacol. 2017;8:391.
Safety
Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018;82(3):178-183.
Brutlag A, Hommerding H. Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats. Vet Clin North Am Small Anim Pract. 2018;48(6):1087-1102.
Larsen C, Shahinas J. Dosage, Efficacy and Safety of Cannabidiol Administration in Adults: A Systematic Review of Human Trials. J Clin Med Res. 2020;12(3):129-141.
Seizures
McGrath S, Bartner LR, Rao S, Packer RA, Gustafson DL. Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy. J Am Vet Med Assoc. 2019;254(11):1301-1308.
Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014;55(6):791-802.
Tang R, Fang F. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017;377(7):699.
Jones NA, Glyn SE, Akiyama S, et al. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure. 2012;21(5):344-352.
Skin Health (Dermatitis)
Petrosino S, Verde R, Vaia M, Allarà M, Iuvone T, Di Marzo V. Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis. J Pharmacol Exp Ther. 2018;365(3):652-663.
Miltner, Noémi and Béke, et al. (Assessment of the anti-inflammatory effects of cannabidiol and its fluorinated derivative in in vitro and in vivo models of atopic dermatitis. International Investigative Dermatology 2018, 2018.05.16-19,
Skin Health (General)
Río CD, Millán E, García V, Appendino G, DeMesa J, Muñoz E. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. Biochem Pharmacol. 2018;157:122-133.
Bíró T, Tóth BI, Haskó G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci. 2009;30(8):411-420.
A Comprehensive Guide to Using CBD for Cats
We hope this guide to CBD for cats has answered all of your questions. We invite you to learn more about CBD through our educational blog. In addition, to hear from some of our verified customers about their success using Lolahemp CBD oil for cats, please visit our customer review page.